Physician profile
Steven Sideris
NPI 1659416238
$1,156.82
in general payments reported to CMS, 2019-2025
10 companies · $350 in 2025
The $350 reported for 2025 was more than what 86% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $484 · 2020: $30.45 · 2021: $82.20 · 2022: $40.00 · 2023: $61.86 · 2024: $109 · 2025: $350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $350 · Food and Beverage: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $350.00 |
| Food and Beverage | $170.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Den-Mat Holdings, LLC | $416.00 | 2019 | |
| Straumann USA LLC | $350.00 | 2025 | |
| Align Technology, INC. | $147.22 | 2019-2024 | Itero Element 5d Plus, Invisalign |
| Orapharma, A Division of Bausch Health US, LLC | $68.94 | 2019-2024 | Arestin, Ossix Plus |
| Dentsply Sirona INC | $54.29 | 2019-2024 | Suresmile |
| Thommen Medical USA, LLC | $40.12 | 2024 | |
| Henry Schein, INC. | $25.00 | 2021 | |
| Zimmer Biomet Holdings, INC. | $24.33 | 2021 | |
| Ultradent Products INC | $15.49 | 2021 | |
| Elevate Oral Care | $15.43 | 2024 | Advantage Arrest, Fluorimax Mint, Fluorimax 5000 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Sideris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.